Abinopharm Reports Positive Clinical Trial Outcomes for Oral Dr.Ergo® L-Ergothioneine in Enhancing Skin Health

Abinopharm, Inc., an innovative nutritional and biopharmaceutical company based in Shelton, Connecticut, USA, is pleased to announce that its partner, EG...

July 07, 2025 | Monday | News
Ferring Pharmaceuticals Announces ESHRE Data Confirming Conventional FSH Dosing for Rekovelle® Matches Follitropin Alfa in IVF

Data presented today at the ESHRE congress builds evidence for conventional-based Follicular Stimulating Hormone (FSH) dosing for Rekovelle® (fol...

July 03, 2025 | Thursday | News
Asahi Kasei Pharma Begins Phase III Trial in Japan of ART-123 for Preventing Chemotherapy-Induced Peripheral Neuropathy

Asahi Kasei Pharma has started trial drug administration in a Phase III study of ART-123 in Japan (generic name: thrombomodulin alfa; marketed as Recomod...

July 03, 2025 | Thursday | News
MaaT Pharma and Clinigen Sign Exclusive European Licensing Deal for Xervyteg® in Acute Graft-Versus-Host Disease

MaaT Pharma and Clinigen signed exclusive long-term licensing and distribution agreement and commercial supply agreement for Xervyteg® (MaaT013),...

July 03, 2025 | Thursday | News
Modella AI and AstraZeneca Forge Multi-Year Alliance to Power Oncology R&D with Multimodal AI

-Modella AI, a leader in artificial intelligence for life sciences,  announced a multi-year agreement with AstraZeneca. Under the agreement, Modella...

July 03, 2025 | Thursday | News
Alvotech and Advanz Pharma Forge Agreement to Commercialise Biosimilar Candidate to Cimzia® Across Europe

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Adva...

July 02, 2025 | Wednesday | News
Artelo Biosciences Reports Positive First-in-Human Data for ART26.12, a First-in-Class FABP5 Inhibitor Targeting Chronic Pain

Artelo Biosciences, Inc. a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people liv...

July 01, 2025 | Tuesday | News
HUTCHMED and AstraZeneca Secure China Approval for ORPATHYS®–TAGRISSO® Combination in EGFR-Mutant NSCLC with MET Amplification

HUTCHMED (China) Limited  announces that the New Drug Application (“NDA”) for the combination of ORPATHYS® (savolitinib) and TAGRISS...

July 01, 2025 | Tuesday | News
Addex Therapeutics Leads CHF 2 Million Investment in Stalicla to Advance Precision Medicine for Autism and Neuropsychiatric Disorders

Addex Therapeutics , a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for ...

July 01, 2025 | Tuesday | News
MGI Tech and Negedia Join Forces to Expand Access to Spatial Transcriptomics and Precision Genomics in Italy

MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in life sciences, today announced a pa...

June 27, 2025 | Friday | News
Liquid Instruments Partners with Scanfil to Onshore Moku Platform Production in Australia

Scanfil and Liquid Instruments have signed a manufacturing outsourcing agreement for Scanfil’s Melbourne plant in Australia. This agreement support...

June 26, 2025 | Thursday | News
GenSight Biologics Completes Upstream Tech Transfer of LUMEVOQ® Manufacturing to Catalent

Upstream phase of LUMEVOQ® manufacturing process successfully transferred Milestone follows successful manufacture of drug product batch to be u...

June 26, 2025 | Thursday | News
Thermosome Reports Promising Phase I Results for THE001 and Regional Hyperthermia in Soft Tissue Sarcoma Patients

Thermosome GmbH, a clinical-stage drug development company focused on targeted tumor therapies, today announced new, encouraging data from its ongoing Ph...

June 24, 2025 | Tuesday | News
Perceptive Discovery Launches FIBRE Consortium with Pfizer, Lantheus, and Lumina to Advance Imaging Biomarkers in Fibrotic Diseases

Perceptive Discovery, a global leader in molecular and functional imaging research, today announced the launch of the FIBRE (Fibrosis Imaging Biomarker R...

June 23, 2025 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close